HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Court Pedersen Selected Research

Community-Acquired Infections

1/2007High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.
1/2007A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.
2/2006Soluble haemoglobin scavenger receptor (sCD163) in patients with suspected community-acquired infections.
1/2006Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Court Pedersen Research Topics

Disease

26Infections
06/2019 - 12/2005
11Acquired Immunodeficiency Syndrome (AIDS)
05/2017 - 09/2003
8Sepsis (Septicemia)
06/2020 - 01/2006
7HIV Infections (HIV Infection)
01/2014 - 01/2006
6Neoplasms (Cancer)
05/2017 - 07/2010
6Fibrosis (Cirrhosis)
03/2016 - 01/2006
6Inflammation (Inflammations)
07/2015 - 07/2007
6Chronic Hepatitis C
06/2014 - 06/2008
5Pneumonia (Pneumonitis)
09/2009 - 05/2007
4Bacteremia
06/2019 - 09/2013
4Cardiovascular Diseases (Cardiovascular Disease)
05/2017 - 03/2011
4Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
11/2015 - 01/2006
4Disease Progression
10/2013 - 12/2002
4Hepatitis B
01/2012 - 09/2004
4Community-Acquired Infections
01/2007 - 01/2006
3Coinfection
05/2017 - 01/2014
3Communicable Diseases (Infectious Diseases)
02/2015 - 01/2006
3Chronic Obstructive Pulmonary Disease (COPD)
01/2015 - 10/2013
3Substance-Related Disorders (Drug Abuse)
08/2011 - 08/2007
3Hepatitis
05/2011 - 01/2006
2Respiratory Tract Infections (Respiratory Tract Infection)
02/2017 - 07/2007
2Shock
06/2016 - 01/2015
2Lymphoma (Lymphomas)
01/2016 - 09/2014
2Chronic Renal Insufficiency
01/2015 - 01/2013
2Liver Cirrhosis (Hepatic Cirrhosis)
02/2014 - 01/2014
2Myocardial Infarction
07/2010 - 06/2010
2Bacterial Infections (Bacterial Infection)
07/2007 - 01/2007
1Bronchiolitis
11/2017
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
11/2017
1Osteonecrosis (Kienbock's Disease)
05/2017
1Respiratory Tract Diseases (Respiratory Tract Disease)
02/2017
1Overweight
10/2016
1Lymphadenopathy
01/2016
1Lymphopenia (Lymphocytopenia)
01/2015
1Pneumococcal Infections
10/2014
1Leukocytosis (Pleocytosis)
09/2014
1Vomiting
09/2014
1Confusion (Bewilderment)
09/2014
1Nausea
09/2014
1Headache (Headaches)
09/2014
1Crohn Disease (Crohn's Disease)
09/2014
1Thrombocytopenia (Thrombopenia)
06/2014
1Hypertension (High Blood Pressure)
06/2014
1Anemia
06/2014
1Renal Insufficiency (Renal Failure)
05/2014
1Viremia
02/2014

Drug/Important Bio-Agent (IBA)

13Pharmaceutical PreparationsIBA
05/2017 - 09/2003
10C-Reactive ProteinIBA
06/2020 - 01/2006
9Ribavirin (Virazole)FDA LinkGeneric
03/2016 - 06/2008
7Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2007
7insulin receptor-related receptor (IRR)IBA
06/2014 - 06/2010
6Anti-Bacterial Agents (Antibiotics)IBA
06/2020 - 03/2007
5RNA (Ribonucleic Acid)IBA
09/2012 - 12/2002
4ProcalcitoninIBA
01/2018 - 01/2006
4InterferonsIBA
03/2016 - 02/2010
3Serum AlbuminIBA
06/2020 - 01/2016
3CytokinesIBA
02/2017 - 01/2007
3Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2007
3AntibodiesIBA
01/2015 - 01/2006
2AlbuminsIBA
06/2020 - 11/2018
2CholesterolIBA
10/2016 - 01/2014
2Biological ProductsIBA
01/2016 - 07/2015
2Complement System Proteins (Complement)IBA
01/2016 - 01/2014
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2015 - 10/2013
2Hyaluronic Acid (Hyaluronan)IBA
02/2014 - 05/2011
2Antiviral Agents (Antivirals)IBA
09/2012 - 08/2007
2peginterferon alfa-2a (Pegasys)FDA Link
09/2012 - 08/2010
2VaccinesIBA
01/2012 - 06/2007
2lipopolysaccharide-binding proteinIBA
01/2007 - 01/2006
2HMGB1 Protein (HMG1)IBA
01/2007 - 01/2007
1CatalaseIBA
06/2019
1Mannose ReceptorIBA
01/2018
1Prednisolone (Predate)FDA LinkGeneric
11/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2017
1Chemokine CCL3IBA
02/2017
1Monocyte Chemoattractant ProteinsIBA
02/2017
1A 7 (A-7)IBA
06/2016
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2016
1Bone Morphogenetic Protein 1IBA
01/2016
1Amyloid (Amyloid Fibrils)IBA
01/2016
1Immunoglobulins (Immunoglobulin)IBA
01/2016
1Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2015
1CatecholaminesIBA
02/2015
1IS 33IBA
01/2015
1GlucocorticoidsIBA
01/2015
1Azathioprine (Imuran)FDA LinkGeneric
09/2014
1DNA (Deoxyribonucleic Acid)IBA
09/2014
1Inosine TriphosphataseIBA
06/2014
1Inosine Triphosphate (ITP)IBA
06/2014
1PyrophosphatasesIBA
06/2014
1Protease Inhibitors (Protease Inhibitor)IBA
02/2014
1Reverse Transcriptase InhibitorsIBA
02/2014
1SterolsIBA
01/2014
1Prothrombin (Factor II)IBA
01/2014
1lathosterolIBA
01/2014

Therapy/Procedure

21Therapeutics
06/2020 - 12/2005
13Highly Active Antiretroviral Therapy (HAART)
11/2017 - 05/2005
2Duration of Therapy
06/2014 - 03/2011
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2015
1Art Therapy
01/2015